Medicare Enrolled

Dr. Ruth Sarmiento, M.D.

Hematology & Oncology · Stockbridge, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1045 SOUTHCREST DR, Stockbridge, GA 30281
6782890549
In practice since 2006 (20 years)
NPI: 1609893072 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sarmiento from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarmiento? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sarmiento

Dr. Ruth Sarmiento is a hematology & oncology specialist in Stockbridge, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sarmiento performed 347 Medicare services across 246 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sarmiento received a total of $3,789 from 53 pharmaceutical and/or device companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sarmiento is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 347 Medicare services $3,789 industry payments

Medicare Practice Summary

Medicare Utilization ↗
347
Medicare services
Bottom 29% in GA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
246
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
147 $47 $213
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
104 $24 $129
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
37 $62 $210
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $59 $317
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
16 $104 $400
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $105 $484
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
12 $40 $115
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,789
Total received (2018-2024)
Avg $541/year across 7 years
Top 49% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
126
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,761 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,952
2023
$767
2022
$304
2021
$79
2020
$15
2019
$158
2018
$514

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$200
Novartis Pharmaceuticals Corporation
$197
ABBVIE INC.
$134
Daiichi Sankyo Inc.
$99
Merck Sharp & Dohme LLC
$97
Regeneron Healthcare Solutions, Inc.
$80
GENZYME CORPORATION
$74
Tempus AI, Inc
$73
Eisai Inc.
$73
Karyopharm Therapeutics Inc.
$73
AstraZeneca Pharmaceuticals LP
$72
Adaptive Biotechnologies Corporation
$61
Celgene Corporation
$59
Janssen Biotech, Inc.
$55
PharmaEssentia USA Corporation
$54
Takeda Pharmaceuticals U.S.A., Inc.
$47
GlaxoSmithKline, LLC.
$42
JAZZ PHARMACEUTICALS INC.
$38
Blueprint Medicines Corporation
$33
Astellas Pharma US Inc
$33
BeiGene USA, Inc.
$26
Pharmacosmos Therapeutics Inc.
$25
Novocure Inc.
$25
Ipsen Biopharmaceuticals, Inc
$24
Bayer Healthcare Pharmaceuticals Inc.
$23
Lilly USA, LLC
$23
Stemline Therapeutics Inc.
$22
Exelixis Inc.
$21
Mirati Therapeutics, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$20
Kyowa Kirin, Inc.
$20
Coherus Biosciences Inc.
$20
Alexion Pharmaceuticals, Inc.
$19
Immunocore Limited
$18
Agios Pharmaceuticals, Inc.
$17
ARRAY BIOPHARMA INC
$16
Genentech USA, Inc.
$16
Top 3 companies account for 27.3% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$276
PFIZER INC.
$250
Novartis Pharmaceuticals Corporation
$232
Karyopharm Therapeutics Inc.
$198
Regeneron Healthcare Solutions, Inc.
$139
ABBVIE INC.
$134
AstraZeneca Pharmaceuticals LP
$127
Gilead Sciences, Inc.
$125
TESARO, Inc.
$124
Amgen Inc.
$121
Exelixis Inc.
$105
Seattle Genetics, Inc.
$103
Daiichi Sankyo Inc.
$99
Merck Sharp & Dohme LLC
$97
Genentech USA, Inc.
$84
Bayer HealthCare Pharmaceuticals Inc.
$84
GENZYME CORPORATION
$74
Tempus AI, Inc
$73
Eisai Inc.
$73
Bayer Healthcare Pharmaceuticals Inc.
$69
Janssen Biotech, Inc.
$68
Foundation Medicine, Inc.
$66
Incyte Corporation
$66
AbbVie, Inc.
$64
Adaptive Biotechnologies Corporation
$61
Celgene Corporation
$59
Coherus Biosciences Inc.
$57
PharmaEssentia USA Corporation
$54
Stemline Therapeutics Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$47
Seagen Inc.
$44
GlaxoSmithKline, LLC.
$42
JAZZ PHARMACEUTICALS INC.
$38
ARRAY BIOPHARMA INC
$36
Blueprint Medicines Corporation
$33
Astellas Pharma US Inc
$33
EMD Serono, Inc.
$30
Sobi, Inc
$29
Pharmacyclics LLC, An AbbVie Company
$28
BeiGene USA, Inc.
$26
Pharmacosmos Therapeutics Inc.
$25
Novocure Inc.
$25
Ipsen Biopharmaceuticals, Inc
$24
Lilly USA, LLC
$23
Mirati Therapeutics, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$20
ImmunoGen, Inc.
$20
Kyowa Kirin, Inc.
$20
Alexion Pharmaceuticals, Inc.
$19
G1 Therapeutics, Inc.
$18
Immunocore Limited
$18
Agios Pharmaceuticals, Inc.
$17
Sunovion Pharmaceuticals Inc.
$17
Top 3 companies account for 20.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · APTIOM · AYVAKIT · Aliqopa · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · COSELA · Cabometyx · DARZALEX · DOPTELET · ELAHERE · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Erleada · FRUZAQLA · Fabhalta · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUTATHERA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nubeqa · OJJAARA · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PYRUKYND · Padcev · Phesgo · Pomalyst · Poteligeo · REBLOZYL · Rituxan · SARCLISA · SCEMBLIX · TAGRISSO · TIVDAK · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Venclexta · XPOVIO · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Stockbridge?
Compare hematology & oncology specialists in the Stockbridge area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
147
Per 100K population
59.9
County median income
$81,612
Nearest hospital
PIEDMONT HENRY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sarmiento is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sarmiento experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Sarmiento performed 147 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sarmiento receive payments from pharmaceutical companies?
Yes. Dr. Sarmiento received a total of $3,789 from 53 companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarmiento's costs compare to other hematology & oncology specialists in Stockbridge?
Dr. Sarmiento's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarmiento) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →